Searchable abstracts of presentations at key conferences in endocrinology

ea0059p107 | Diabetes & cardiovascular | SFEBES2018

Anacardium occidentale upregulates GLP-I and Insulin Gene Expression in Normoglycemic Rats

Ukwenya Victor , Omotuyi Olaposi , Enejo Ojochenemi

Anacardium occidentale is a multi-purpose tree of the anacardae family with great economic and medicinal value. The leaf of the tree has been reported to possess hypoglycaemic and anti-diabetic properties. However, literature is devoid of any molecular basis for the potent effects observed. This study evaluated the molecular mechanisms underlying the efficacy and safety of the leaves by investigating glucagon-like peptide 1, insulin and kidney injury molecule genes us...

ea0065p252 | Metabolism and Obesity | SFEBES2019

Molecular interactions of cashew leaf (Anacardium occidentale) derived compounds with anti-diabetic targets: in silico and in vivo studies

Ukwenya Victor , Omotuyi Olaposi , Enejo Ojochenemi , Alese Olutayo

Anacardium occidentale (cashew tree) belongs to the Anacardiaceae family and has been well used in folklore medicine for the treatment of various ailments such as gastrointestinal disorders, hypertension and diabetes. Literature is replete with reported anti-diabetic actions of cashew leaf. The molecular mechanism of the hypoglycemic activity of A. occidentale was investigated in this study. Insulin, Glucagon like peptide-1 (GLP-1), dipeptidyl peptidase-4 (DP...

ea0059p051 | Bone and calcium | SFEBES2018

Chromolaena odorata and Tithonia diversifolia synergistically stimulate kidney erythropoietin and repress cyclin-dependent kinase inhibitors in the bone marrow of Wistar rats

Omotuyi Olaposi , Nash Oyekanmi , Ukwenya Victor , Gbadamosi Emmanuel

Aim: Chromolaena odorata and Tithonia diversifolia have been combined as folkloric treatment for pediatric anemia. However, the underlying molecular mechanism of this pharmacology has not been established. This study sought to establish the effects of these plants on erythropoietin (kidney), and erythropoietin receptor (bone marrow) expression and to monitor cyclin-dependent kinase inhibitors, and FasL/FAS signaling mechanism therefrom....